Epstein–Barr Virus‐Associated Smooth Muscle Tumor After Kidney Transplantation: A French Multicenter Retrospective Study
- Published on 05/07/2025
- Reading time: 4 min.
Laurène Tardieu1, Dany Anglicheau2, Rebecca Sberro‐Soussan2, Mathilde Lemoine3, Léonard Golbin4, Ophélie Fourdinier5, Julie Bruneau6, Marina Charbit7, Tchao Meatchi8, Jean‐Emmanuel Serre9, Moglie Le Quintrec9, Alexandre Karras1, Eric Thervet1, Hélène Lazareth 1
1
Service de Néphrologie et Hémodialyse
Hôpital Européen Georges Pompidou, AP‐HP, Université Paris Cité
Paris
France
2
Service de Transplantation rénale
Hôpital Universitaire Necker‐Enfants‐Malades, AP‐HP, Université Paris Cité
Paris
France
3
Service de Néphrologie
CHU de Rouen
Rouen
France
4
Service de Néphrologie
CHU de Rennes
Rennes
France
5
Service de Néphrologie et Transplantation rénale
CHU d'Amiens
Amiens
France
6
Service d'Anatomopathologie
Hôpital Universitaire Necker‐Enfants‐Malades, AP‐HP, Université Paris Cité
Paris
France
7
Service de Néphrologie Pédiatrique
Hôpital Universitaire Necker‐Enfants‐Malades, AP‐HP, Université Paris Cité
Paris
France
8
Service d'Anatomopathologie
Hôpital Européen Georges Pompidou, AP‐HP, Université Paris Cité
Paris
France
9
Service de Néphrologie Transplantation
Université de Montpellier
Montpellier
France
Abstract
Background Epstein–Barr virus (EBV) is a herpesvirus linked to nine different human tumors and lymphoproliferative disorders. Immunosuppression promotes EBV‐driven malignancies. The most frequent EBV‐induced malignancies are lymphomas and nasopharyngeal carcinoma. By promoting smooth muscle proliferation, EBV can induce EBV‐associated smooth muscle tumors (EBV‐SMT). EBV‐SMT is a rare oncological entity for which no current guideline...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Nephrology
Receive our newsletter to stay up to date with the latest news in Nephrology
